Literature DB >> 17602130

Influence of drug company authorship and sponsorship on drug trial outcomes.

Tongeji Tungaraza1, Rob Poole.   

Abstract

Studies of drug treatments are more likely to report favourable outcomes when they are funded by the pharmaceutical industry. We compared drug trials reported in three major psychiatric journals to investigate these influences. Independent studies were more likely to report negative findings than industry-funded studies. However, the involvement of a drug company employee had a much greater effect on study outcome than financial sponsorship alone.

Entities:  

Mesh:

Year:  2007        PMID: 17602130     DOI: 10.1192/bjp.bp.106.024547

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  18 in total

1.  Medical reversal: why we must raise the bar before adopting new technologies.

Authors:  Vinay Prasad; Adam Cifu
Journal:  Yale J Biol Med       Date:  2011-12

2.  The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Wolf-Dieter Ludwig; Klaus Lieb
Journal:  Dtsch Arztebl Int       Date:  2010-04-23       Impact factor: 5.594

3.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

4.  Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.

Authors:  Susannah L Rose; Monika K Krzyzanowska; Steven Joffe
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

5.  Transparent texts: authors of scientific articles often have conflicts of interest. It is important for these to be communicated transparently to the readers.

Authors:  Christopher Baethge
Journal:  Dtsch Arztebl Int       Date:  2008-10-03       Impact factor: 5.594

Review 6.  Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

Authors:  Dirk Eyding; Monika Lelgemann; Ulrich Grouven; Martin Härter; Mandy Kromp; Thomas Kaiser; Michaela F Kerekes; Martin Gerken; Beate Wieseler
Journal:  BMJ       Date:  2010-10-12

Review 7.  Aggressive behaviour in adults with intellectual disability: defining the role of drug treatment.

Authors:  Patricia Oliver-Africano; Declan Murphy; Peter Tyrer
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

8.  Focusing on Cause or Cure?: Priorities and Stakeholder Presence in Childhood Psychiatry Research.

Authors:  Lauren C Milner; Mildred K Cho
Journal:  AJOB Prim Res       Date:  2014-01-01

9.  Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry.

Authors:  J E Cohen; M Zeller; T Eissenberg; M Parascandola; R O'Keefe; L Planinac; S Leischow
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

Review 10.  Industry sponsorship and research outcome.

Authors:  Andreas Lundh; Joel Lexchin; Barbara Mintzes; Jeppe B Schroll; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2017-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.